BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9869180)

  • 1. Homozygous G20210A prothrombin gene mutation without thromboembolic events: a case report.
    Alatri A; Franchi F; Moia M
    Thromb Haemost; 1998 Dec; 80(6):1028-9. PubMed ID: 9869180
    [No Abstract]   [Full Text] [Related]  

  • 2. Homozygous G20210A transition in the prothrombin gene associated with severe venous thrombotic disease: two cases in a French family.
    Zawadzki C; Gaveriaux V; Trillot N; Bauters A; Watel A; Alhenc-Gelas M; Preudhomme C; Jude B
    Thromb Haemost; 1998 Dec; 80(6):1027-8. PubMed ID: 9869179
    [No Abstract]   [Full Text] [Related]  

  • 3. Coagulation factor II activity determination is not useful as a screening tool for the G20210A prothrombin gene allele.
    Gruenewald M; Germowitz A; Beneke H; Guethner C; Griesshammer M
    Thromb Haemost; 2000 Jul; 84(1):141-2. PubMed ID: 10928488
    [No Abstract]   [Full Text] [Related]  

  • 4. The VITA project: prothrombin G20210A mutation and venous thromboembolism in the general population.
    Tosetto A; Missiaglia E; Frezzato M; Rodeghiero F
    Thromb Haemost; 1999 Nov; 82(5):1395-8. PubMed ID: 10595625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation screening for thrombophilia: two cases with factor V Cambridge without activated protein C resistance.
    ten Cate AJ; van de Hoek YT; Reitsma PH; ten Cate H; Smits P
    Thromb Haemost; 2002 May; 87(5):919-20. PubMed ID: 12038799
    [No Abstract]   [Full Text] [Related]  

  • 6. What clinical significance has the presence of the homozygous G20210A prothrombin gene mutation in a healthy woman?
    Martlew VJ; Perez-Casal M; Alfirevic Z; Toh CH
    Thromb Haemost; 2000 Aug; 84(2):355-6. PubMed ID: 10959715
    [No Abstract]   [Full Text] [Related]  

  • 7. Venous thromboembolism in a young woman with combined homozygosity for factor V Leiden and prothrombin G20210A mutations.
    Leonard M; Gala JL; Verschuren F; Coche E; Deneys V; Hainaut P
    Haematologica; 2005 Nov; 90 Suppl():ECR30. PubMed ID: 16266921
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevalence of the prothrombin gene 20210A mutation in thrombophilic and healthy Algerian subjects.
    Helley D; Chafa O; Yaker NL; Reghis A; Fischer AM
    Thromb Haemost; 1999 Nov; 82(5):1554-5. PubMed ID: 10595654
    [No Abstract]   [Full Text] [Related]  

  • 9. G20210A prothrombin gene variant and clinical outcome in patients with a first acute coronary syndrome.
    Burzotta F; Leone AM; Paciaroni K; De Stefano V; Rossi E; Testa L; Giannico F; Leone G; Maseri A; Crea F; Andreotti F
    Haematologica; 2004 Sep; 89(9):1134-8. PubMed ID: 15377476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prothrombin G20210A mutation is a risk factor for sudden hearing loss in young patients.
    Patscheke JH; Arndt J; Dietz K; Zenner HP; Reuner KH
    Thromb Haemost; 2001 Oct; 86(4):1118-9. PubMed ID: 11686335
    [No Abstract]   [Full Text] [Related]  

  • 11. Homozygotes for prothrombin gene 20210 A allele in a thrombophilic family without clinical manifestations of venous thromboembolism.
    Souto JC; Mateo J; Soria JM; Llobet D; Coll I; Borrell M; Fontcuberta J
    Haematologica; 1999 Jul; 84(7):627-32. PubMed ID: 10406905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemostatic risk factors and arterial thrombotic disease.
    Reiner AP; Siscovick DS; Rosendaal FR
    Thromb Haemost; 2001 Apr; 85(4):584-95. PubMed ID: 11341490
    [No Abstract]   [Full Text] [Related]  

  • 13. Familial thrombophilia is an oligogenetic disease: involvement of the prothrombin G20210A, PROC and PROS gene mutations.
    Boinot C; Borgel D; Kitzis A; Guicheteau M; Aiach M; Alhenc-Gelas M
    Blood Coagul Fibrinolysis; 2003 Feb; 14(2):191-6. PubMed ID: 12632031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of the TaqMan-PCR for genotyping of the prothrombin G20210A mutation and of the thermolabile methylenetetrahydrofolate reductase mutation.
    Happich D; Madlener K; Schwaab R; Hanfland P; Pötzsch B
    Thromb Haemost; 2000 Jul; 84(1):144-5. PubMed ID: 10928490
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevalence of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations in 200 healthy Jordanians.
    Eid SS; Rihani G
    Clin Lab Sci; 2004; 17(4):200-2. PubMed ID: 15559724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic APC resistance in carriers of the A20210 prothrombin mutation is associated with an increased risk of venous thrombosis.
    Castaman G; Tosetto A; Simioni M; Ruggeri M; Madeo D; Rodeghiero F
    Thromb Haemost; 2001 Sep; 86(3):804-8. PubMed ID: 11583311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Frequency of prothrombin gene G20210A variant in the 3'-untranslated region in Zhuang ethnic Chinese].
    Chang JH; Ma Y; Zhang GS
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Jun; 22(3):341-3. PubMed ID: 15952132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium.
    Martinelli I; De Stefano V; Taioli E; Paciaroni K; Rossi E; Mannucci PM
    Thromb Haemost; 2002 May; 87(5):791-5. PubMed ID: 12038778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A three-generation family presenting five cases of homozygosity for the 20210 G to A prothrombin variant.
    Morange PE; Barthet MC; Henry M; Fontanet H; Aillaud MF; Alessi MC; Juhan-Vague I
    Thromb Haemost; 1998 Nov; 80(5):859-60. PubMed ID: 9843184
    [No Abstract]   [Full Text] [Related]  

  • 20. Foetal growth restriction in children with prothrombotic risk factors.
    von Kries R; Junker R; Oberle D; Kosch A; Nowak-Göttl U
    Thromb Haemost; 2001 Oct; 86(4):1012-6. PubMed ID: 11686317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.